ASH News Daily 2017 - Issue 1 - C-1

ASH NEWS DAILY
®

59th Annual Meeting of the American Society of Hematology
Issue 1, Section C
Saturday, December 9, 2017
Atlanta, GA
Read this issue online at

www.hematology.org/ashnewsdaily2017_saturday
Follow us on Twitter using #ASH17

ATTENDEE
SERVICES
ASH Central
Located in Building B, Level 1, Hall B1 of the
Georgia World Congress Center, ASH Central
is a place where meeting attendees can
gather to collaborate, relax, view sessions
remotely, or purchase ASH products. Offered
at ASH Central:
* ASH Live: Remote Session Viewing
* Collaboration Rooms
* ASH Store
* Selfie Zone
* ASH Foundation Donor Lounge
* ASH Trainee Lounge
* ASH News TV
* Hematology MeetUps
ASH Store
ASH has a variety of offerings to aid hematologists in their professional development.
Peruse the latest ASH educational products
and services, including:
* American Society of Hematology SelfAssessment Program (ASH®SAP),
Sixth Edition
* How I Treat Compendium: A Compendium for the Practicing Hematologist
* Hematology 2017, ASH Education
Program
* 2017 ASH Annual Meeting Webcast
Hematology MeetUps
Multiple seating areas with tables and chairs
will be placed in the lobby areas of the center to enable attendees to meet one another
for informal, impromptu conversations and
small meetings. Look for MeetUp areas
designated by the red stars on the convention center maps in this section.
Wheelchair-accessible ASH Shuttles
ASH has partnered with Kushner & Associates for wheelchair-accessible ASH shuttles
from hotels on the shuttle route. Please see
the ASH shuttle supervisor at the Georgia
World Congress Center during shuttle hours.
Restaurant Reservation Desk
Located in Building A, Level 4 of the International Boulevard Concourse at the Georgia
World Congress Center, the Restaurant Reservations Desk offers complimentary restaurant
reservation services and features brochures
on attractions in the metro Atlanta area.

IN THIS SECTION
ASH-IPIG Abstract
Achievement Awards
C-3
Saturday Product
Theaters
C-3
Exhibit Hall Map
C-6

Beat AML Update

T

he Leukemia & Lymphoma
Society (LLS) has announced
the expansion of the Beat
AML Master Trial, which was originally launched in October 2016. The
past four decades have seen little
change in the standard of treatment
for acute myeloid leukemia (AML;
usually a combination of toxic chemotherapies). ASH recently partnered with LLS to help spread the
word about this pivotal trial, which
looks to test new, innovative therapies for AML - the cause of more
than 10,000 deaths every year.
To date, more than 130 patients
have enrolled in the trial, and seven leading cancer centers across
the United States are participating,
including the Ohio State University Comprehensive Cancer Center,
Memorial Sloan Kettering Cancer
Center, Oregon Health & Science
University, Harold C. Simmons
Comprehensive Cancer Center at
University of Texas Southwestern,
University of Chicago Comprehensive Cancer Center, University of

Colorado Cancer Center, and the
University of Maryland Marlene
and Stewart Greenebaum Comprehensive Cancer Center. Four major
biopharmaceutical companies are
providing investigational targeted
therapies, with three more expected
to join soon. The number of active
treatment arms is now five.

The Beat AML Master Trial
should continue for at least two
years, eventually including 500 patients between 15 and 20 clinical
sites. ASH will continue to monitor
this trial in collaboration with LLS,
and update members accordingly.
For more information, visit www.lls.
org/beat-aml.

ASH Congratulates the First Cohort
of MRHAP Winners

T

his year, ASH is proud to announce an entirely new program for underrepresented
minority residents, the ASH Minority Resident Hematology Award
Program (MRHAP), the goal of
which is to provide support for underrepresented minority residents
to conduct hematology-focused research with the intended outcome of
increasing interest in hematology research and choice of fellowship. This
new award program, much like the
MMSAP Flex experience (see page
B-8) is intended to fill the gaps in the
longitudinal pathway from medical student to hematologist by providing underrepresented minority
trainees with additional research opportunities and one-on-one interactions with both a research and career
development mentor. Participants
have the opportunity to perform
research within the full spectrum of
hematology ranging from stem cells

Elisa Quiroz, MD

Samuel Wilson, MD

to sickle cell disease to leukemia.
In addition to a $5,000 research
stipend for laboratory supplies and
statistical support, those selected
also receive a $1,000 travel allowance
to attend the ASH annual meeting;
$1,000 after the ASH annual meeting
for presenting their research at the
Promoting Minorities in Hematology

event; complimentary subscriptions
during residency to Blood, as well as
The Hematologist; the guidance of a research mentor and a career development mentor. Join ASH in congratulating Drs. Elisa Quiroz and Samuel
Wilson, and read more about their
»» MRHAP Page C-26
http://www.hematology.org/ashnewsdaily2017_saturday http://www.lls.org/beat-aml http://www.lls.org/beat-aml
Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 1
